Stay updated on ALT-801 in Overweight and Obese T2DM: Clinical Trial
Sign up to get notified when there's something new on the ALT-801 in Overweight and Obese T2DM: Clinical Trial page.

Latest updates to the ALT-801 in Overweight and Obese T2DM: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ALT-801 Phase 1 study record for overweight and obese adults with type 2 diabetes is now displayed, including study details and participation information, instead of an access-denied page.SummaryDifference47%

- Check21 days agoChange DetectedThe footer’s ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check27 days agoChange DetectedA notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov error page.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden response instead of study details.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating access restrictions. The error view replaces the study details and related navigation with a standard error layout.SummaryDifference17%

Stay in the know with updates to ALT-801 in Overweight and Obese T2DM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 in Overweight and Obese T2DM: Clinical Trial page.